Canvas Dx is the initial and solitary FDA-authorized Software as a Medical Device (SaMD) designed to assist healthcare professionals in diagnosing autism spectrum disorder (ASD) in young children. Leveraging clinically validated artificial intelligence (AI) technology, Canvas Dx supports physicians in the diagnostic process for ASD in children aged 18-72 months who are at risk for developmental delay.
Three distinct and user-friendly inputs are integrated into Canvas Dx:
- A parent/caregiver questionnaire, established through a dedicated app, inquiring about the child's behavior and development.
- A questionnaire completed by video analysts who assess two parent/caregiver-recorded videos of the child.
- An HCP questionnaire filled out by a physician following an evaluation with the child and parent/caregiver, facilitated through a dedicated healthcare provider portal.
The Canvas Dx algorithm processes all three inputs, producing an output for the physician to utilize in conjunction with their clinical expertise. It should be emphasized that Canvas Dx is not meant to serve as a standalone diagnostic tool but rather as a supplement to the diagnostic procedure, intended for prescription use only.
Contact Information:
Email: connect@cognoa.com
Phone: 1.866.4COGNOA (1.866.426.4662)
Indications for Use:
Canvas Dx is designed for use by healthcare providers to assist in diagnosing ASD in patients between 18-72 months who exhibit risk factors for developmental delay based on concerns raised by a parent, caregiver, or healthcare provider. It is not intended as a solo diagnostic method but as an aid during diagnosis and is strictly available by prescription (Rx only).
Contraindications:
There are no contraindications for using Canvas Dx.
Precautions and Warnings:
- The device is exclusively intended for use by healthcare professionals with the requisite training to interpret behavioral assessment results and diagnose ASD.
- It is recommended to use the device alongside patient history, clinical observations, and any additional clinical evidence deemed necessary by the healthcare provider before making diagnostic decisions.
- In cases where the output is inconclusive for ASD, further standardized testing may be necessary to validate the results.
- Canvas Dx is designed for patients whose caregivers are proficient in English (8th-grade reading level or above) and have access to a compatible smartphone with internet connectivity at home.
- The device might yield inaccurate results if used on patients with specific exclusionary conditions, including but not limited to those listed.
- The evaluation utilizing Canvas Dx should be conducted within 60 days of prescription due to the rapid neurodevelopmental changes characteristic of the specified age group.
概述
Canvas Dx 是在由Cognoa, Inc.开发类别 Home & Hobby Freeware 软件。
最新版本是 Canvas Dx 的 1.9.4 2024/07/14 上释放。 它最初被添加到我们的数据库 2024/07/14 上。
Canvas Dx 在下列操作系统上运行: iOS。
用户 Canvas Dx 5 个 5 星的评分,给了它。
2024/11/13 | Intel Wireless Bluetooth 23.90.0.8 |
2024/11/13 | Visual Studio Community 2017 15.9.68 |
2024/11/13 | Visual Studio Community 2019 16.11.42 |
2024/11/13 | Microsoft Visual Studio Installer 3.12.2149.20818 |
2024/11/13 | Visual Studio Community 2022 17.12.0 |
评测
AOMEI Backupper
AOMEI Backupper:可靠的备份和恢复解决方案 |
|
Rockstar Games Launcher
使用 Rockstar Games Launcher 简化您的 Rockstar 游戏体验! |
|
Microsoft ODBC Driver for SQL Server
使用 Microsoft ODBC Driver for SQL Server 进行可靠高效的连接管理 |
|
Comprobación de estado de PC Windows
Optimiza el rendimiento de tu PC con Comprobación de estado de PC Windows |
|
Canon My Image Garden
为佳能用户提供高效的图像管理和编辑工具 |
|
Java SE Runtime Environment
运行 Java 应用程序的基本软件 |